.jpg%3Ftrim%3D0%2C0%2C0%2C0%26width%3D1200%26height%3D800%26crop%3D1200%3A800&w=3840&q=100)
Funeral held for Georgia woman kept on life support until baby could be delivered: ‘Adriana's voice will be heard'
Adriana Smith, the Atlanta mother who was declared brain-dead but kept medically alive under Georgia's anti-abortion law, has been laid to rest.
Smith, who turned 31 while on life support, suffered a catastrophic stroke in February and was declared brain-dead at eight weeks pregnant, but her family had no choice but to keep her alive until doctors delivered her son by emergency C-section.
The case has become a lightning rod for the impact of state-level abortion bans in medical emergencies and has given rise to questions about fetal personhood.
The 'vague' language of Georgia's LIFE Act, which doesn't clearly address cases of brain death, left Smith's family to navigate legal and medical complications during a devastating time, according to advocates.
At Smith's funeral Saturday at Fairfield Baptist Church in Lithonia, just outside of Atlanta, loved ones addressed the difficulty of the nurse's death and vowed her voice 'will be heard,' 11Alive reports.
'Adriana's life mattered and we're gonna make sure ... from this house to the state house to Washington, D.C., that Adriana's voice will be heard,' Evangelist Triana Arnold James told the congregation, according to the outlet.
Democratic State Rep. Park Cannon also rallied behind enacting 'Adriana's Law,' which she said would 'affirm that individuals retain agency over their bodies and medical decisions even under restrictive fetal personhood regimes.'
'We believe bodily autonomy should be upheld in Georgia by enacting Adriana's Law,' Cannon said.
Smith's younger sister Naya spoke at the service, where she praised her sibling's 'love, kindness and wisdom.'
In a poignant tribute at the end of the service, the Atlanta Metropolitan Nursing Honor Guard formally relieved Smith of her duties as a nurse and recited the 'final call of duty' in her honor, 11Alive reported.
Smith's son Chance was born prematurely earlier this month, weighing about 1 pound 13 ounces.
He is still in a neonatal intensive care unit. Smith has another 7-year-old son.
Smith's mother, April Newkirk, said that doctors told her Georgia's anti-abortion law required that her daughter remain on life support until the fetus was able to survive outside the womb.
The law was among a wave of anti-abortion measures enacted in Republican-led states after the Supreme Court revoked a constitutional right to abortion care by overturning the landmark Roe v Wade ruling in 2022.
Georgia's law restricts abortion once cardiac activity is detected, or at roughly six weeks of pregnancy, before most women know they are pregnant. The law also grants personhood rights to a fetus, effectively providing the same full rights and legal protections as a person.
'I'm not saying we would have chosen to terminate her pregnancy. But I'm saying we should have had a choice,' Newkirk told 11Alive in a previous interview.
Newkirk felt the same way after Chance's birth.
'I think all women should have a choice about their body,' she said. 'And I think I want people to know that.'
Smith's loved ones gathered on June 15 to mark her 31st birthday and celebrate her life. Her life support machine was turned off a few days later.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
29 minutes ago
- The Sun
Boy, 18, left with horrific bowel disease for life after hay fever tablets wreaked havoc in his gut
CHRONIC use of popular medications may lead to inflammatory bowel disease, experts have warned. Their warning comes after an 18-year-old boy' s daily use led to him developing colitis. 2 The teenage boy had been dealing with debilitating daily headaches and decided to self-treat with daily over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are a class of medications used to reduce pain, inflammation, and fever. They're commonly used for conditions like headaches, menstrual cramps, sprains, strains, and arthritis, with common examples including ibuprofen, naproxen, and aspirin. In a report published in Cureus, medical experts detailed how the boy had also been taking diphenhydramine for seasonal allergies - which is a combination of an antihistamine and NSAID. More than two years after taking the pills daily, he began experiencing hematochezia - bleeding from the rectum - and fatigue. He had no significant past medical history, but revealed to doctors he'd been taking 600mg of over-the-counter NSAIDs two times a day. A colonoscopy revealed significant mucosal inflammation in his colon, suggestive of colitis due to chronic NSAID use, which led to him being officially diagnosed with inflammatory bowel disease (IBD). Colitis is one of the main types of IBD. Doctors discharged the boy after his vital signs (heart rate and blood pressure) showed to be stable. He was given oral oral prednisone and mesalamine for IBD, was advised to discontinue NSAID use, and was instructed to return in six weeks for a repeat colonoscopy. I was going to the toilet 40 times a day - FA Cup star opens up on his bowel disease torment But he ultimately failed to follow up. The authors of the report wrote: "This case highlights the adverse effects associated with chronic NSAID use." They added: "Although the patient was diagnosed with inflammatory bowel disease, the absence of a strong family history and the presence of chronic NSAID use raise the possibility of drug-induced colitis. 2 "This underscores the importance of obtaining a detailed medication history and ensuring close outpatient follow-up." What is colitis? Colitis, or ulcerative colitis as it's also known, is where the colon and rectum become inflamed. The exact cause is unknown, although it's thought to be the result of a problem with the immune system. Inherited genes may also be a factor of the development of the condition - you may be more likely to have it if you have a close relative with the condition. And where and how you live could affect your chances. The NHS advises: "The condition is more common in urban areas of northern parts of western Europe and America. "Various environmental factors that may be linked to uclerative colitis have been studied, including air pollution, medicine and certain diets. "Although no factors have so far been identified, countries with improved sanitation seem to have a higher population of people with the condition. "This suggests that reduced exposure to bacteria may be an important factor." NSAIDs, some heart and migraine medications, hormone medicines, and antibiotics have previously been linked to colitis. Signs of ulcerative colitis The main symptoms are: recurring diarrhoea, which may contain blood, mucus or pus tummy pain needing to poo frequently You may also experience extreme tiredness (fatigue), loss of appetite and weight loss. The severity of the symptoms varies, depending on how much of the rectum and colon is inflamed and how severe the inflammation is. For some people, the condition has a significant impact on their everyday lives. Some people may go for weeks or months with very mild symptoms, or none at all (remission), followed by periods where the symptoms are particularly troublesome (flare-ups or relapses). During a flare-up, some people with ulcerative colitis also experience symptoms elsewhere in their body; which are known as extra-intestinal symptoms. These can include: painful and swollen joints (arthritis) mouth ulcers swollen fat under the skin causing bumps and patches – this is known as erythema nodosum irritated and red eyes problems with bones, such as osteoporosis In many people, no specific trigger for flare-ups is identified, although a gut infection can occasionally be the cause. Stress is also thought to be a potential factor. You should see a GP as soon as possible if you have symptoms of ulcerative colitis and you haven't been diagnosed with the condition. Source: NHS
Leader Live
30 minutes ago
- Leader Live
GB News announces expansion into the US
The news channel, launched in 2021, will open a new bureau in Washington DC as it launches its services across the Atlantic. The two-hour programme will begin in September from a studio 'close to the White House' and will 'bring British audiences closer than ever to the political news which unfolds each day in America'. The programme will feature 'headline-making exclusives, thought-provoking interviews with major figures, and in-depth analysis of the Trump presidency as well as stories from across the US', according to GB News. The move includes an extension of GB News' distribution across the US, with content to be made available free to American audiences. Turner said: 'With the gutsiest guests and the most iconic backdrops, I intend to keep viewers up late. Fronting the next stage of GB News's evolution is both a huge honour and an immense responsibility, and I cannot wait to represent the people's channel on a global stage. 'We will be disrupting the late-night TV space as the next day's papers land in the UK and America's prime-time analysis gears up. This affords us the chance to deliver a unique UK-USA hybrid of political, cultural and social issues from the start-line of global politics. 'We will fulfil the need for a British voice with an international perspective to help our viewers get a sense of who's really on their side. 'Tapping into Washington's heartbeat and delivering real-time perspective with editorial edge, the show will be alive, and a conversation that's punchy, intelligent and unmissable. What happens in DC reverberates in GB and we will capture every moment. 'Our highly engaged British audience understands how events in the US are directly impacting government policy and living standards here. 'We have a job to do: bridging the gap between British and American politics in the fearless style that typifies GB News. 'We will include the very best guests that Washington has to offer, alongside quintessentially British voices in an unparalleled assessment of events on both sides of the Atlantic. 'This isn't just a media experiment, this is a market intervention. And I look forward to leading it from the front.' Turner, 51, who began presenting her own show on GB News in 2022, previously hosted a talk show on LBC and has appeared on ITV's This Morning and Good Morning Britain. Michael Booker, GB News editorial director, said: 'This is a huge moment for GB News as we grow our presence and deliver more of the fearless journalism that defines us. 'The world's biggest political story is playing out in Washington, and its impact is being felt daily in towns and cities across Britain. 'More than ever before, what happens in the USA is having huge consequences, both socially and economically, for the people of Britain. 'We've seen time and again this year that a decision made on one day in Washington DC is felt the next day in Washington, Tyne and Wear. 'It's essential the people's channel is right there, reporting live, asking the tough questions, and telling it like it is. 'While others scale back on live free coverage, GB News is investing in our content. 'Our new Washington investment, our expanded programming and our brilliant on-the-ground team will ensure we're not just reporting on the story but that we're right at the heart of it.'
The Independent
37 minutes ago
- The Independent
India appeals to Donald Trump for a ‘big, beautiful trade pact'
Indian finance minister Nirmala Sitharaman has said India would love to have a 'big, beautiful' trade deal with the US, as Washington and New Delhi race to clinch an agreement before the 9 July deadline when punitive tariffs are set to kick in. However, the minister also laid out India's red lines as she expressed hopes for an interim Bilateral Trade Agreement (BTA) between the two 'strong economies.' Her remarks came after US president Donald Trump last week said a 'very big' deal with India was 'coming up' soon, even though negotiators on both sides appeared to have hit a deadlock over key issues. The US is India's largest trading partner, with the value of their bilateral trade reaching $190bn recently. But after taking office for his second term in January, Mr Trump branded India a "tariff king" and a "big abuser" of trade ties. He has threatened to impose an additional tariff of up to 26 per cent on Indian goods. Although steep, the levy is still lower than the total 104 per cent imposed on China, 49 per cent on Cambodia, and 46 per cent on Vietnam. The additional duties are due to kick back in after a 90-day pause, targeting products like machinery, pearls, mineral fuels, and more. 'I'd love to have an agreement, a big, good, beautiful one; why not?" Ms Sitharam said in an interview with The Financial Express. "The US is one of our leading trade partners, topmost if anything. At the junction we are in, and given our growth goals and ambition to reach Viksit Bharat [developed India] by 2047, the sooner we have such agreements with strong economies, the better they will serve us. So, I'd rather put my own statement on (Trump's)," she added. She nonetheless noted that protecting India's agriculture and dairy industries have been among the 'major red lines' in the BTA talks with the US. "The negotiating team ensured that the industry's concerns were all taken on board before they sat at the table. Agriculture and dairy have been among the very big red lines, where a high degree of caution has been exercised," she said in the interview. The finance minister pushed back against Mr Trump's accusations that India was a 'tariff king', saying the label is 'unjustified' and that India's tariffs against the US were modest and within the World Trade Organisation 's guidelines. "We have only eight duties, inclusive of zero tariffs. There have been drastic cuts in both the July and February budgets. The effective tariff rates are far below the WTO thresholds. So, for India to be called a 'tariff king' is absolutely unjustified," she said. A major sticking point in the India–US trade deal is agriculture, where deep structural differences persist. The US wants greater access for its big-ticket farm exports like wheat, corn, cotton, and genetically modified (GM) crops to narrow its trade deficit, but India has resisted, citing the need to protect food security and the livelihoods of millions of small farmers. Unlike the US, where large-scale, heavily subsidised farming is the norm, India's agriculture is dominated by small landholdings and low productivity. High tariffs – up to 150 per cent – are used by India to shield its farmers from cheaper imports. The US argues these barriers are unfair, while India sees them as essential for survival. After Mr Trump unveiled his Liberation Day tariffs, India acted swiftly by reducing tariffs on select US goods, including motorcycles and whiskey, and offered concessions in the agricultural and defence sectors in an effort to ease tensions with Washington. The two countries have engaged in a series of high-level negotiations aimed at finalising a trade deal before the full impact of Trump's new tariffs takes effect. But progress has been slowed by political sensitivities in India, particularly around the farming and auto industries, which remain key domestic concerns. According to Bloomberg, Indian negotiators in Washington have extended their stay to resolve these differences and reach a deal before the deadline. People familiar with the matter said the negotiations that were supposed to run until 27 June were extended by a day, raising hopes of a timely trade deal.
